# A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects

> **NCT07560033** · PHASE1 · NOT_YET_RECRUITING · sponsor: **CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.** · enrollment: 192 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** CM326(formulation 1)
- **DRUG:** CM326(formulation 2)

## Key facts

- **NCT ID:** NCT07560033
- **Lead sponsor:** CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07560033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07560033, "A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07560033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*